MatsukiyoCocokara & Co
3088.TMEDIUMCore · Weight: 8%· Data as of 2026-05-28
Investment Thesis
Japan's largest drugstore chain (3,328+ stores). FY2026 results: Revenue ¥1,117.4B (+5.3%), OP ¥84.9B (+3.5%), NI ¥55.7B (+2.0%). FY2027 guidance: ¥1,155B revenue (+3.4%), OP ¥87.5B (+3.0%). 2031 targets: Revenue ¥1.3T, EBITDA margin ≥13%, ROE ≥12%. DOWNGRADE NOTE: Inbound tourism thesis weakening — China visitors down 56.8% April 2026 (5th consecutive monthly decline). JTB forecasts full-year 2026 inbound down 2.8%. Japan tax-free shopping shifting to refund-based system Nov 2026 — removes in-store convenience for tourists. Shiseido Q1 2026 -3% YoY from same China-Japan tension effect. Domestic business remains solid; tourist upside now a risk, not a tailwind.
Risk
1) China inbound tourism collapse: Chinese visitors down 56.8% April 2026 — 5th consecutive monthly decline. China-Japan diplomatic tensions show no near-term resolution. 2) Tax-free shopping system revision Nov 2026: shift to refund-based model removes in-store purchase convenience. May reduce impulse cosmetics buys. 3) JTB full-year forecast: 41.4M total visitors in 2026, down 2.8% from 2025. Inbound headwind may persist into 2027. 4) Shiseido Q1 2026 sales -3% from same China-Japan tensions — signals supply chain of tourist cosmetics demand under pressure. 5) Domestic competition: AINZ&TULPE, Welcia, Tsuruha competing in urban high-traffic zones.
Monitoring Trigger
REVIEW if: China monthly visitors recover to >500,000 or >50% of 2019 level → re-rate back to HIGH. TRIM if: Same-store-sales decline >3% QoQ driven by tourist segment, OR FY2027 earnings miss guidance. HOLD: Domestic drugstore business stable, 2031 targets intact. Valuation reasonable at PE 16.8x.
Key Dates
Update History
New stock added via supply chain exploration. Japan's largest drugstore, preferred tourist cosmetics destination, PE 15.85x, zero debt, 36% analyst upside. HIGH conviction.
DOWNGRADED HIGH→MEDIUM. FY2026: ¥1,117.4B rev (+5.3%), ¥84.9B OP (+3.5%). China tourists -56.8% April 2026. JTB forecasts 2026 inbound -2.8%. Tax-free shopping system change Nov 2026. Thesis weakening.
Key Metrics
Business Segments
| Segment | Revenue | Share | Description |
|---|---|---|---|
| Matsumotokiyoshi Group | Core drugstore operations, flagship brand | ||
| Cocokara Fine Group | Pharmacy and health/beauty retail | ||
| Management Support | Group logistics, procurement, admin |
Supply Chain Evidence
| Evidence | Customer | Product | Detail |
|---|---|---|---|
| confirmed | Korean tourists | Japanese skincare, face masks, cosmetics | Matsumoto Kiyoshi cited in Korean travel blogs as mandatory stop; Japanese cosmetics cheaper than Korean market |
| confirmed | Chinese tourists | Premium cosmetics, vitamins, supplements | Chinese tourists are highest per-capita cosmetics spenders in Japan; Matsukiyo is primary destination |
| probable | Taiwanese tourists | Cosmetics, OTC medicines, health products | Taiwan #2 inbound market; drugstores a standard itinerary stop |
| confirmed | Inbound Tourists (China/Korea/Taiwan/Southeast Asia) | Japanese cosmetics, skincare, OTC medicines | Company FY2026 disclosure: inbound tourism boosted cosmetics sales. 3,328+ stores incl. urban tourist zones. BUT Chinese visitors -56.8% April 2026.[source](2026-05-12) |
Sources & References
Peer Comparison
| Company | PE | Fwd PE | ROE | Op Margin | FCF |
|---|---|---|---|---|---|
| ABC-Mart,Inc. | 14.78 | N/A | 12.1% | 16.5% | +¥28B |
| Pan Pacific International Holdings | 26.6 | 20.5 | 17.0% | 7.1% | N/A |
| MatsukiyoCocokara & Co | 16.8 | N/A | 10.6% | 7.6% | N/A |
| Isetan Mitsukoshi | 31.36 | ~28 | 9.7% | ~5.7% | N/A |
| Oriental Land (Tokyo Disney Resort) | 37.51 | ~40-48 | 13% | 23.9% | positive but capex-heavy |
| Japan Airport Terminal | 16.1 | N/A | 14.7-22.3% | 13.2% | positive |
| Sanrio Company | 21.01 | ~24 | 44.0% | 44.7% | positive |